Leigh MacMillan Archive — Page 7 of 84

March 31, 2025

$5 million gift from Springer-Lu Family Foundation to support VUMC’s Aspirnaut program

Aspirnaut is a K-20 STEM (science, technology, engineering and mathematics) pipeline that supports immersive summer research experiences for talented high school and undergraduate students.

March 25, 2025

C. diff uses toxic compound to fuel growth advantage

The findings of a new research study increase understanding of the molecular drivers of C. diff infection and point to novel therapeutic strategies aimed at a pathogen that causes about half a million infections in the U.S. each year.

March 20, 2025

Primary Care Autism Team honored for developing new care pathway

“This program dramatically improved continuity of care, implementation of best practices, and patient/provider education.”

(iStock image)
March 14, 2025

Blood formation and disorders expert Stuart Orkin to present Discovery Lecture March 27

Orkin’s research led to a gene therapy for sickle cell disease and beta-thalassemia; it is the first Food and Drug Administration-approved CRISPR-based gene therapy.

March 12, 2025

Potential therapeutic for Duchenne muscular dystrophy takes step forward

Positive findings from a clinical trial support further study of the investigational drug ifetroban to treat cardiac complications, the leading cause of death in patients with DMD.

March 10, 2025

VUMC to develop AI technology for therapeutic antibody discovery

The approach will address “bottlenecks” that slow the traditional antibody discovery process, and it aims to make it possible to generate monoclonal antibody therapies against any target of interest.